We cant apply the findings to humans due to different metabolism and physiology
Key Highlights (Top 5 Key Players) Eli Lilly and Company - Leading with Mounjaro and Zepbound (tirzepatide), dominating dual GLP-1/GIP agonist segment for superior weight loss and diabetes control
Goal: Studied for telomerase activation, telomere maintenance and circadian/melatonin regulation effects reported mostly in older Russian and preclinical work, not established in humans [5] [6]
For all we know, combining both classes of medications may result in a greater benefit although, again, testing hasnt yet examined this
2027 (mid-to-late) earliest possible FDA approval decision, assuming a standard 10-month priority review
When should I take glutathione supplements